Recent News 61 : International Conference Announcement; ONE HEALTH, ONE SOLUTION: Bacteriophages Against AMR, Goa, INDIA

-

International Conference Announcement

ONE HEALTH, ONE SOLUTION: Bacteriophages Against AMR

Date: January 17, 2026
Location: Department of Biological Sciences, BITS Pilani, K.K. Birla Goa Campus, Goa, India

Taken from : https://www.bits-pilani.ac.in/goa/ohos2026/

Introduction

The Department of Biological Sciences at BITS Pilani, K.K. Birla Goa Campus, is pleased to announce an international conference on a topic of critical global importance:
"ONE HEALTH, ONE SOLUTION: Bacteriophages Against AMR."
This one-day event will serve as a dynamic forum for scientists, researchers, clinicians, regulatory professionals, and industry stakeholders to collaborate on innovative solutions to one of the most pressing public health crises of our time—Antimicrobial Resistance (AMR).

Conference Scope

Antimicrobial Resistance is a growing threat that transcends human health, impacting animals, agriculture, and the environment. Aligned with the One Health philosophy, this conference emphasizes the interconnectedness of ecosystems and the urgent need for integrative solutions.

The focus of the event will be on bacteriophages—viruses that target and destroy specific bacteria—as promising, sustainable alternatives to antibiotics. The scientific program will cover a wide range of topics including:

  • Phage discovery and characterization

  • Clinical applications of bacteriophage therapy

  • Regulatory frameworks and translational research

  • Environmental and veterinary uses of phages

  • AMR surveillance and intervention strategies

Theme

Emerging Biotechnological Solutions Against AMR

This year’s theme highlights cutting-edge innovations in biotechnology that offer promising alternatives to conventional antimicrobials. By fostering interdisciplinary collaboration, the conference aims to advance both scientific knowledge and real-world applications in the fight against AMR.

About the Host Institution

BITS Pilani, K.K. Birla Goa Campus is one of India’s premier institutions for science and technology education and research. Nestled across 180 acres of serene landscape overlooking the Zuari River, the campus boasts state-of-the-art laboratories, a modern library, auditoriums, and dedicated research centers.

Key facilities include:

  • Central Sophisticated Instrumentation Facility (CSIF)

  • The Anuradha and Prashanth Palakurthi Centre for Artificial Intelligence

  • Center for Innovation, Incubation and Entrepreneurship

  • BITS BIRAC BioNEST Incubator supporting startups in health and environmental technology

Call for Abstracts

Participants are invited to submit abstracts for oral presentations, contributed talks, or posters.

  • Submission Deadline: October 31, 2025

  • Notification of Acceptance: November 10, 2025

  • Registration Deadline:

    • Regular Fee: By December 15, 2025

    • Late Fee: After December 15, 2025

Registration Fees

Participant TypeModeRegular Fee (₹)Late Fee (After Dec 15) (₹)
Faculty (India)Attendee₹2,500 (Offline) / ₹3,000 (Online)₹3,500 (Offline) / ₹4,000 (Online)
Presenter₹3,000 (Offline) / ₹3,500 (Online)₹4,000 (Offline) / ₹4,500 (Online)
Research Scholars (India)Attendee₹1,500 (Offline) / ₹2,000 (Online)₹2,500 (Offline) / ₹3,000 (Online)
Presenter₹2,500 (Offline) / ₹3,000 (Online)₹3,500 (Offline) / ₹4,000 (Online)
Foreign ParticipantsFlat₹5,000 (Attendee) / ₹6,000 (Presenter)₹6,000 / ₹7,000

Invited Speakers

Details of keynote and invited speakers will be announced shortly.

Scientific and Organizing Committee

Information about the committee will be updated soon.

Sponsors

Sponsorship opportunities are available. A detailed list of sponsors will be shared soon.

Conference Venue

Department of Biological Sciences
BITS Pilani, K.K. Birla Goa Campus
Zuarinagar, Goa – 403726, India

Travel Information

By Air

  • Goa International Airport (Dabolim): 5 km from campus

  • Manohar International Airport (Mopa): ~55 km from campus

Recommended Transport:

  • Pre-paid taxis (Dabolim to campus ~ ₹500, Mopa ~ ₹4,000)

  • Government-approved ride service: Goa Miles

By Train

  • Vasco da Gama (~10 km)

  • Karmali (~20 km)

  • Madgaon (~22 km)
    Taxi fares range between ₹2,000–₹2,500 from stations to campus.

By Road

The campus is accessible via NH17B. Note: City buses do not service the campus directly.

Accommodation

Accommodation details will be updated on the conference website shortly.

Contact

Prof. Malabika Biswas
Associate Professor
Department of Biological Sciences
BITS Pilani, K.K. Birla Goa Campus
Zuarinagar – 403726, Goa, India
Email and phone number will be updated soon

Stay tuned for updates on speakers, scientific sessions, and partner organizations. Join us in Goa this January to be part of a global movement advancing sustainable, science-driven solutions to antimicrobial resistance.


For more informations check : https://www.bits-pilani.ac.in/goa/ohos2026/

Comments

Post a Comment

Popular posts from this blog

History Part 12 : Post-War Stagnation and Phage Therapy’s Marginalization in the West (1945–1980s)

-
Image
Post-War Stagnation and Phage Therapy’s Marginalization in the West (1945–1980s) The period following World War II marked a decisive turning point in the trajectory of phage therapy in Western medicine. Despite the promising results bacteriophages had demonstrated prior to the war as potential antibacterial agents, the decades after 1945 saw a dramatic decline in interest, funding, and scientific engagement with phage therapy in the United States and much of Western Europe. This marginalization can be attributed to a confluence of scientific, sociopolitical, and economic factors that reshaped the landscape of infectious disease treatment and research. Artistic View One of the key contributors to this decline was the overwhelming optimism surrounding the newly discovered class of antibiotics. The post-war pharmaceutical revolution brought forward a series of broad-spectrum antibiotics such as streptomycin, tetracycline, and chloramphenicol, which were viewed as miracle drugs capable o...
Read more

The Phage Therapy in the spotlight !

-
Image
Bacteriophages: Ancient Predators and the Next Frontier in Medicine In the animated documentary The Deadliest Being on Planet Earth , the Kurzgesagt team delves into the world of bacteriophages—viruses that prey exclusively on bacteria. With vibrant visuals and precise narration, the video introduces viewers to an invisible ecosystem where microscopic hunters orchestrate life-and-death dramas that shape the biosphere. These entities, though virtually unknown to the general public, may soon become central to the future of medicine. At the heart of the video lies a paradox: bacteriophages (or "phages") are among the most abundant biological entities on Earth—outnumbering all other organisms combined—yet their therapeutic potential has been largely sidelined in the antibiotic era. The video outlines the historical trajectory of phage research, spotlighting Félix d’Hérelle’s early 20th-century work and the rise of phage therapy, only to show how it was later eclipsed by the dis...
Read more

Paper 3 : Phage Therapy May Treat Drug Resistance in Patients With Cystic Fibrosis, Study Finds

-
Image
Phage Therapy May Treat Drug Resistance in Patients With Cystic Fibrosis, Study Finds June 13, 2025 "Yale's university researchers find a new approach to combatting antimicrobial resistance. Antimicrobial resistance, in which germs like bacteria and fungi no longer respond to medicines, is a rising global threat. When antibiotics and other drugs become ineffective, infections can become difficult or impossible to treat, leading to an increase in the spread and severity of disease. In a new study, published in Nature Medicine , a team of researchers at the Center for Phage Biology and Therapy at Yale discovered a novel approach that may revolutionize the fight against antimicrobial resistance. Jon Koff, MD, with a patient Credit: Robert A. Lisak For the study, the research team investigated the use of phage therapy—the use of viruses, or phages, to target and kill bacteria—to help patients with cystic fibrosis, a disease in which antimicrobial resistance is a significant issue....
Read more